Prof. Zafar Iqbal, PhD PDr
King Saud bin Abdulaziz University for Health Sciences College of Applied Medical Sciences, King Abdulaziz Medical City, King Abdullah International Medical Research Center
0000-0002-1334-6372
About
Dr. Zafar Iqbal carried out his PhD research on “Clinical and molecular genetic studies of leukemia” at University of the Punjab Lahore Pakistan and Rui-Jin Hospital, Shanghai Institute of Hematology, Shanghai Jiao-Tong University School of Medicine China, with some part of it at University of Tokyo Hospital Japan and King Faisal Specialist Hospital & Research Centre Riyadh.. After completion of his doctoral research work, he was awarded the degree of doctor of philosophy (PhD) in Molecular Genetics in 2007. From 2007-2008, he completed his post-doctoral fellowship in “Clinical Hematology/Oncology and Functional Medical Genomics” at Rui-Jin Hospital, Shanghai Institute of Hematology, Shanghai Jiao-Tong University School of Medicine China.
Dr. Zafar Iqbal served medical biotechnology unit at Pakistan Atomic Energy Commission, Shaukat Khanum Memorial Cancer Hospital & Research Centre Lahore, University of the Punjab Lahore and Ammar Medical Complex, Chughtai Lahore Laboratories Pakistan as consultant, scientist and faculty members. From 2010-2012, he served King Saud University College of Medicine, Riyadh, Saudi Arabia and pioneered molecular genetics pathology unit which is providing molecular testing for advanced diagnosis, prognostic stratification and anti-cancer treatment monitoring for hematological diseases, solid tumors and familial genetic diseases. He joined College of Applied Medical Sciences (CAMS), KSAU-HS Riyadh in November 2012 as assistant professor. Currently, he is teaching subjects of Molecular diagnostics, Medical Genetics, Medical Biology, Research Methodology and Genomic Medicine/Molecular Pathology at CAMS, College of Medicine and Department of Pathology, King Abdulaziz Medical City, National Guard Health Affairs, Alahsa. He is also chairing and giving his input in many committees related to Research, teaching and Quality Assessment and Academic Accreditation (AAA).
Dr. Zafar Iqbal has published a number of research articles and publications in ISI-indexed research journals. He also has many research awards from European and North American research societies. He also holds membership of many cancer, hematology and genetic research societies including American Association of Cancer Research, European Hematology Association and American Society of Hematology.
Employment
-
King Saud bin Abdulaziz University for Health Sciences College of Applied Medical Sciences2016 - Present
-
King Abdulaziz Medical City2016 - Present
-
King Abdullah International Medical Research Center2016 - Present
-
King Abdulaziz Hospital
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (298)
- Omics and artificial intelligence integration for stratifying blast crisis CML using COSMIC signatures and pan-cancer precision drug repurposing Save
- Multi-Omics and AI-/ML-Driven Integration of Nutrition and Metabolism in Cancer: A Systematic Review, Meta-Analysis, and Translational Algorithm Save
- Investigating Family History Status, Frequency of BRCA1/BRCA2 Mutations and Molecular Subtypes of Breast Cancer in the Highly Consanguineous Eastern Saudi Arabia Population: Implications in the Post-COVID-19 Era Save
- Abstract 5994: Investigating druggability of myeloid and lymphoid lineage gene mutations in advanced phase CML by employing drug discovery tools: Implications in fatal blast crisis CML precision oncology Save
- Repositioning of FDA-approved anti-cancer drugs for fatal blast crisis CML by integrated high-throughput genomic and artificial intelligence-based drug discovery analyses of pan-leukemic genetic abnormalities: Implications in post-COVID-19 era Save
- Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice Save
- AI-Guided Repurposing of FDA-Approved Anti-Leukemic Molecularly Targeted Therapies for Fatal Blast Crisis Chronic Myeloid Leukemia: Integrative Genomics for Precision Medicine of Relapsed/Refractory Cancers in the Post-Pandemic Era Save
- Cardiac Filaminopathy: Prevalence, Clinical Features, and Genetic Insights in Saudi Arabia Save
- Abstract A027 Investigations on association of month of birth and seasonality with chromosomal abnormalities of prognostic significance and disease incidences in pediatric acute lymphoblastic leukemia in Saudi Arabia Save
- Investigations on druggable gene mutations related to AML/ALL lineage genes in Advanced Phases of CML: Implications in patient-tailored therapy of blast crisis CML in TKI era Save